|
2106
|
Valdecoxib
|
Selecive COX-2 inhibitor |
€85.00 |
|
1411
|
Vandetanib
|
VEGFR and EGFR tyrosine kinase inhibitor |
€55.00 |
|
1384
|
Varenicline dihydrochloride
|
Nicotinic acetylcholine receptor agonist |
€95.00 |
|
2074
|
Varenicline tartrate
|
Selective α4β2 nicotinic acetylcholine receptor (nAChR) partial agonist |
€95.00 |
|
1867
|
Vasopressin antagonist 1867
|
Orally available and selective V1b receptor antagonist |
€125.00 |
|
1637
|
Vatalanib
|
VEGFR tyrosine kinase inhibitor |
€75.00 |
|
1893
|
VE 821
|
Inhibitor of the DNA damage response kinase ATR |
€105.00 |
|
2452
|
VE 822
|
Selective ATR inhibitor that decreases survival of pancreatic cancer cells |
€110.00 |
|
1727
|
Venlafaxine hydrochloride
|
SNRI |
€65.00 |
|
1608
|
VER 155008
|
Hsp70 inhibitor |
€95.00 |
|
2685
|
Vercirnon
|
CCR9 antagonist |
Recently added
|
€135.00 |
|
2377
|
Vidofludimus
|
Oral immunomodulatory drug that inhibits dihydroorotate dehydrogenase (DHODH) |
€125.00 |
|
1631
|
Vildagliptin
|
DPP4 inhibitor |
€95.00 |
|
2044
|
Voriconazole
|
Orally bioavailable CYP51 inhibitor; Antifungal agent |
€105.00 |
|
1988
|
VU 0029767
|
PAM of mAChR M1 that potentiates the agonistic effect of Ach |
€120.00 |